A systematic review of the quality and impact of anxiety disorder meta-analyses

Ipser, Jonathan; Stein, Dan J.

doi:10.1007/s11920-009-0044-7

Cited by 11 publications

(5 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous studies evaluated the methodological quality of MAs in depression 50.2% [ 18 – 21 ] and anxiety 57.2% [ 22 ] using QUOROM checklist. In addition, the reporting quality of MAs in other fields e.g., radiology, and neurosurgery ranged between 31.1% and 85.2% using PRISMA; while the methodological quality of MAs in these references ranged between 47.3% and 72.7% using AMSTAR [ 6 , 12 , 19 , 21 , 23 , 24 ].…”

Section: Discussionmentioning

confidence: 99%

Is the Best Evidence Good Enough: Quality Assessment and Factor Analysis of Meta-Analyses on Depression

et al. 2016

View full text Add to dashboard Cite

BackgroundThe quality of meta-analyses (MAs) on depression remains uninvestigated.ObjectiveTo assess the overall reporting and methodological qualities of MAs on depression and to explore potential factors influencing both qualities.MethodsMAs investigating epidemiology and interventions for depression published in the most recent year (2014–2015) were selected from PubMed, EMBASE, PsycINFO and Cochrane Library. The characteristics of the included studies were collected and the total and per-item quality scores of the included studies were calculated based on the two checklists. Univariate and multivariate linear regression analyses were used to explore the potential factors influencing the quality of the articles.ResultsA total of 217 MAs from 74 peer-reviewed journals were included. The mean score of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was 23.0 of 27 and mean score of Assessment of Multiple Systematic Reviews (AMSTAR) was 8.3 of 11. Items assessing registration and protocol (14.2%, 37/217) in PRISMA and item requiring a full list of included and excluded studies (16.1%, 40/217) in AMSTAR had poorer adherences than other items. The MAs that included only RCTs, pre-registered, had five more authors or authors from Cochrane groups and the MAs found negative results had better reporting and methodological qualities.ConclusionsThe reporting and methodological qualities of MAs on depression remained to be improved. Design of included studies, characteristics of authors and pre-registration in PROSPERO database are important factors influencing quality of MAs in the field of depression.

show abstract

Section: Discussionmentioning

confidence: 99%

Is the Best Evidence Good Enough: Quality Assessment and Factor Analysis of Meta-Analyses on Depression

et al. 2016

View full text Add to dashboard Cite

show abstract

“…This was based on the reasoning that if a particularly large effect existed between patients and controls, then authors might believe their results to be of particular novelty and, hence, worthy of publication in a high impact factor journal. Indeed, journal impact has been shown to be a helpful predictor variable for meta-analytic treatments of psychiatric research themselves (Ipser and Stein 2009). We utilized Hirsch’s h-index since it is easily computable given available citation data unlike traditional impact factors which are formally computed relatively infrequently or require a paid subscription to obtain (e.g.…”

Section: Discussionmentioning

confidence: 99%

Study factors influencing ventricular enlargement in schizophrenia: A 20year follow-up meta-analysis

2012

View full text Add to dashboard Cite

A meta-analysis was performed on studies employing the ventricular-brain ratio to compare schizophrenic subjects to that of normal controls. This was a follow-up to a similar meta-analysis published in 1992 in which study-, in addition to clinical-, factors were found to contribute significantly to the reported difference between patients with schizophrenia and controls. Seventy-two (N=72) total studies were identified from the peer reviewed literature, 39 from the original meta-analysis, and 33 additional studies published since which met strict criteria for inclusion and analysis– thus representing ~30 years of schizophrenia ventricular enlargement research. Sample characteristics from schizophrenics and controls were coded for use as predictor variables against within sample VBR values as well as for between sample VBR differences. Additionally, a number of factors concerning how the studies were conducted and reported were also coded. Obtained data was subjected to unweighted univariate as well as multiple regression analyses. In particular, results indicated significant differences between schizophrenics and controls in ventricular size but also the influence of the diagnostic criteria used to define schizophrenia on the magnitude of the reported VBR. This suggests that differing factors of the diagnostic criteria may be sensitive to ventricular enlargement and might be worthy of further examination. Interestingly, we observed an inverse relationship between VBR difference and the number of co-authors on the study. This latter finding suggests that larger research groups report smaller VBR differences and may be more conservative or exacting in their research methodology. The diagnostic criteria used for defining schizophrenia were also predictive of between group differences. Analyses weighted by sample size provided identical conclusions. The effects of study factors such as these are helpful for understanding the variation in the size of the reported differences in VBR between patients and controls as well as for understanding the evolution of research on complex clinical syndromes employing neuroimaging morphometrics.

show abstract

“…This feature culminates into multiple forms of anxiety disorder in which these individuals dwell on feelings of extreme anxiety and fear. Elevated personal, social and economic liability precipitate to anxiety disorders [24]. It is common for anxiety disorders to be associated with other psychological conditions especially major depressive disorder [25].…”

Section: Iran Embargoes and Mental Healthmentioning

confidence: 99%

The Implications of Sanctions on Civilian Mental Health and Quality of Life Iranian: An Overview

Tahan,

Azari,

Saleem

2023

Preprint

View full text Add to dashboard Cite

background: The Islamic Republic of Iran has been under sanctions since 1979. These sanctions were further reinforced between the years 2005 and 2012. This study utilizes available data from Iran post-sanctions to review the impact of economic sanctions on both the mental health and the quality of life of Iranian citizens.Methods: A comprehensive scoping review was conducted to identify studies examining the impact of sanctions on health in Iran. Searches were initiated in 2012 using PubMed/Medline, Embase, Web of Science, Scopus, and the Scientific Information Database (Iranian Database) with keywords such as sanctions, implications, mental health, quality of life, civilian mental health, and Iran. Subsequent to the screening process, secondary reports and letters to the editor were excluded. Only original studies—those collecting data via observation, interviews, surveys, experiments, or literature reviews—were retained for analysis. In addition to these search strategies, reference scanning was undertaken to identify additional articles pertinent to the scope of the current study. This thorough approach facilitated the discovery of relevant and significant articles exploring the effects of sanctions against Iran on the mental health and overall well-being of its civilian population. Following the search, duplicate articles were meticulously identified and removed by the authors. Data were subsequently extracted and summarized, focusing on study characteristics and the observed effects of sanctions on civilian mental health and quality of life in Iran.Result: Out of 165 items identified in the preliminary search, ten articles met the inclusion criteria. These selected articles highlighted the pronounced effects of sanctions on various health-related domains.Conclusion: Since 2012, Iran has been subject to intensified sanctions. There is evidence to suggest that the economic sanctions, imposed by Western nations, and have exerted a negative and detrimental impact on the health of individual Iranians.

show abstract

A systematic review of the quality and impact of anxiety disorder meta-analyses

Cited by 11 publications

References 30 publications

Is the Best Evidence Good Enough: Quality Assessment and Factor Analysis of Meta-Analyses on Depression

Is the Best Evidence Good Enough: Quality Assessment and Factor Analysis of Meta-Analyses on Depression

Study factors influencing ventricular enlargement in schizophrenia: A 20year follow-up meta-analysis

The Implications of Sanctions on Civilian Mental Health and Quality of Life Iranian: An Overview

Contact Info

Product

Resources

About